On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Trxade Group Inc. (NASDAQ: MEDS) Subsidiaries’ Visionary Telehealth Services Help Limit Impact of Global Viruses

  • Pioneering supplier-to-pharmacy tech platform builder Trxade Group Inc. helps small, community-based pharmaceutical businesses be competitive with larger chains by sourcing drugs at discount prices and promoting transparency in business operations
  • Trxade Group has been developing its subscribers’ access to licensed medical professionals through telehealth services that are both convenient to the patient and significant in their ability to limit the number of people visiting hospitals and offices
  • Amid the sweeping, deadly impact of the seasonal flu and the rising novel coronavirus epidemic, Trxade’s online access to physicians is a timely preventative service
  • Trxade Group Inc. recently announced its uplisting to the Nasdaq Capital Market and rang the exchange’s opening bell, changing its ticker from ‘TRXD’ to ‘MEDS’
  • The company’s network of pharmaceutical partners continues to grow, serving a large percentage of the nation’s 24,000 independent pharmacies

Innovative B2B health services provider Trxade Group Inc. (NASDAQ: MEDS) is helping to reduce exposure to deadly viruses sweeping the planet through the patient empowerment actions of its wholly owned subsidiaries.

As seasonal flu virus infections continue to claim the lives of tens of thousands of Americans and hospitalizes hundreds of thousands of people worldwide (http://nnw.fm/vsI9O), the rise and spread of the novel coronavirus COVID-19 has drawn attention to international measures to stop a deadly, vaccine-less illness by first locking down an entire province (in China), and most recently an entire nation (in Italy), while other communities worldwide close public gathering venues or attempt to assure attendees that adequate health measures are being taken to limit their exposure to such viruses (http://nnw.fm/6ASjE).

Trxade Group’s support of community-based, independent pharmacies, as well as the acquisition of Community Specialty Pharmacy’s online access operation last year (http://nnw.fm/lIW5E) and the establishment of the “Bonum Health Hub” online portal initiative this year (http://nnw.fm/7Xw4G) seems almost prescient in nature given the viral outbreaks’ impact even on access to hospital facilities and their providers (http://nnw.fm/wHRR5).

On March 10, Trxade Group announced the launch of a new membership service by its virtual healthcare subsidiary Bonum Health and its DelivMeds concierge medication delivery operation. The new service allows subscribers to obtain three premium medical teleconferencing visits and free prescription delivery per month, according to a company news release (http://nnw.fm/d32UE).

Bonum’s telehealth services utilize patients’ personal smart tech devices in a private, HIPPA compliant manner that delivers access to board-certified physicians from virtually anywhere the patient may choose to be.

“Teleconferencing with a board-certified provider for assurance via online consultation is quick, easy, and relatively inexpensive. These services free patients from unnecessary exposure or resorting to urgent care facilities and hospital emergency rooms,” Trxade Group’s news release states. “With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold; Telemedicine removes the barrier of self-doubt and complacency in the current climate of world-wide viral infections.”

Trxade Group is building a growing platform of integrated drug procurement, delivery and healthcare services to facilitate price transparency and increased profit margins for independent pharmacies within its network as well as pharmaceutical product sellers.

The company recently uplisted its common stock to the Nasdaq Capital Market, while also announcing it expected gross proceeds of $5.2 million from the sale of common stock in a public offering (http://nnw.fm/Yhg4C).

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork.


Select A Month

NetworkNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 212.418.1217